Tocopherol-Anchored Liposomes for Stable Sub-50 Nm Gene Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing liposomal particles, particularly small unilamellar vesicles (SUVs), face challenges such as instability and aggregation leading to inter-particle fusion, limiting their use in therapeutics due to low surface density modification techniques that anchor DNA on both sides of the lipid bilayer.
Innovation Solution
The use of tocopherol-modified oligonucleotides with a lipophilic end and a non-lipophilic end, such as RNA or DNA, to anchor into the lipid bilayer, creating a dense layer that increases stability and surface density, allowing for smaller particle sizes and improved colloidal stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If post modification technique with cholesterol molecules is used to anchor DNA into the lipid bilayer, then DNA anchoring is achieved, but surface density modification is limited
Solution Approach 1:
The patent changes the chemical structure of the anchoring molecule from cholesterol to tocopherol (vitamin E). This parameter change in the lipophilic anchor enables higher surface density modification because tocopherol-modified oligonucleotides can be incorporated more efficiently into the lipid bilayer during liposome formation, achieving up to 1000-fold increases in surface density compared to conventional methods
Solution Approach 2:
The patent creates a composite structure by combining tocopherol (a lipophilic vitamin) with oligonucleotides to form tocopherol-modified oligonucleotides. This composite material serves as an effective anchor that integrates into the lipid bilayer while maintaining high DNA surface density, resolving the contradiction between anchoring capability and modification efficiency
2Length of moving object
If small unilamellar vesicles (SUVs) are used to reduce particle size, then particle size is reduced, but stability and aggregation resistance decrease
Solution Approach 1:
The patent changes the surface chemistry parameter by introducing tocopherol-modified oligonucleotides with high surface density. This creates a dense protective layer on the liposome surface that provides steric and electrostatic stabilization, preventing aggregation even at small particle sizes below 50 nanometers, thus maintaining colloidal stability while achieving reduced particle size
Solution Approach 2:
The patent creates a dense shell layer of oligonucleotides that copies the stabilizing function of larger liposomes onto smaller SUVs. This dense surface layer of tocopherol-anchored DNA/RNA molecules replicates the protective effect of larger particle size, preventing aggregation and maintaining stability at reduced dimensions
3Reliability
If DNA is anchored on both sides of the lipid bilayer, then anchoring is achieved, but manufacturing complexity increases
Solution Approach 1:
The patent segments the anchoring function from the stabilizing function. The tocopherol-modified oligonucleotides are incorporated during liposome formation, with tocopherol anchors in the bilayer and oligonucleotide strands extending outward. This segmentation allows effective anchoring and stabilization without requiring complex post-modification procedures, reducing manufacturing complexity while maintaining reliability
Solution Approach 2:
The patent performs preliminary incorporation of tocopherol-modified oligonucleotides during the liposome formation process itself, rather than requiring subsequent post-modification steps. This preliminary action ensures proper anchoring and orientation from the beginning, achieving reliable DNA anchoring while simplifying the overall manufacturing process by eliminating complex secondary modification steps
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The tocopherol-modified liposomal particles maintain stability at sizes below 50 nanometers, enhance colloidal stability, and improve bio-distribution by increasing surface charge, facilitating efficient gene regulation and drug delivery without the need for ancillary transfection agents.
Implementation Method 1
The lipophilic end, which comprises tocopherol... to anchor into the lipid bilayer
Implementation Method 2
enhance colloidal stability, and improve bio-distribution by increasing surface charge
Data Source
AI summary
Liposomes termed as small unilamellar vesicles (SUVs), can be synthesized in the 20-50 nm size range, but encounter challenges such as instability and aggregation leading to inter-particle fusion. This limits their use as a therapeutic delivery agent. Increasing the surface negative charge of SUVs, via the attachment of anionic entities such as DNA/RNA, increases the colloidal stability of these vesicles. Additionally, the dense spherical arrangement and radial orientation of nucleic acids exhibits unique chemical and biological properties, unlike their linear counterparts. These liposomal particles, are non-toxic and though anionic, can efficiently enter cells without the aid of ancillary cationic transfection agents in a non-immunogenic fashion. These exceptional properties allow their use as delivery agents for gene regulation in different therapies and offer an alternative platform to metal core spherical nucleic acids.